A Scientific E-Poster to be presented at the 2021 ARRS Virtual Annual Meeting found the COVID-19 'Safer at Home' order resulted in a significant decline in radiology ordering utilization, outpatient consultations, and emergency department (ED) visits.
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Revealing a mechanism by which diets rich in ultra-processed foods damage our health, experiments with rats established that certain compounds, which form when food is heat-treated during production, increase the risk of diseases such as chronic kidney disease. The study found that regularly eating foods cooked or processed at high temperatures, including roast meats,
New study identifies a novel approach for tailored treatment that could be more effective for patients with the chronic disease
In vitro treatment of cells with these molecules reduced the expression of a gene that plays a key role in viral cell entry and a cytokine receptor.
In a randomized clinical trial published in the journal PAIN, researchers found participants with moderate to severe irritable bowel syndrome (IBS) who were knowingly treated with a pharmacologically inactive pill -- referred to as an honest or open-label placebo -- reported clinically meaningful improvements in their IBS symptoms.
Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat, since its causes have not yet been adequately researched. An international research consortium led by MedUni Vienna has now succeeded in identifying a new prognostic factor for PSC from liver biopsies. This is so-called cellular ER stress.
Using patient data from multiple locations, scientists used mathematical models to estimate an "eliciting dose" -- or the amount of peanut protein that will cause or elicit an allergic reaction in a certain percentage of peanut sensitive patients.
UC San Diego scientists have taken the connection between wisdom, loneliness and biology one step further, reporting that wisdom and loneliness appear to influence -- and/or be influenced by -- microbial diversity of the gut.
Wild Biotech, a preclinical stage drug discovery & development company emerging out of stealth mode, today announces the publication of its first major paper, which appears in the journal Science. The study mapped the gut microbiota of animals in the wild on an unprecedented scale, adding millions of potentially novel microbiome-based therapeutics for human diseases to the company's already massive database. Wild will use these findings to first tap its database for targets in inflammatory, immune and gastrointestinal diseases.